September 27, 2016 11:47 PM ET

Healthcare Providers and Services

Company Overview of Seattle Children's Hospital

Company Overview

Seattle Children's Hospital operates a child health care and pediatric center in the United States. The company offers adolescent gynecology, medicine, behavioral, and substance abuse programs; and ambulatory infusion, anesthesia, audiology, bioethics consultation, blood disorders, cancer, cardiac surgery, children with special needs, complex care, craniofacial center, critical care medicine, dental medicine, dialysis, eating disorders, endocrinology/diabetes, family advisory council, financial counseling, and gastroenterology services. The company also provides thoracic surgery, genetics, growth and feeding dynamics, gynecology, health information management, hematology, insurance and inter...

4800 Sand Point Way NE

Seattle, WA 98105

United States

Founded in 1907





Key Executives for Seattle Children's Hospital

Chief Executive Officer and Trustee
Chief Financial Officer and Senior Vice President
Surgeon-In-Chief, Senior Vice President, President of CUMG, and Trustee
President of Seattle Children's Hospital Research Institute
Compensation as of Fiscal Year 2016.

Seattle Children's Hospital Key Developments

Seattle Children's T-Cell Immunotherapy Clinical Trial for Children With Relapsed Leukemia Shows 93% Complete Remission Rate

Seattle Children's announced that 39 of 42 patients treated in a Phase 1 clinical trial using genetically reprogrammed T cells to treat relapsed or refractory acute lymphoblastic leukemia (ALL) have achieved complete remission, showing no detectable leukemia cells in the most sensitive tests. Patients treated in the trial, known as Pediatric Leukemia Adoptive Therapy-02 (PLAT-02), had less than a 20% chance of survival upon enrollment using current treatments. Seattle Children's will launch Phase 2 of the trial this month, with the aim to enroll 70 patients in 2016. The PLAT-02 trial includes patients with ALL who have relapsed after a bone marrow transplant, or who are unable to get into remission to proceed with a bone marrow transplant. Using T-cell immunotherapy, the research team led by Dr. Mike Jensen at the Ben Towne Center for Childhood Cancer Research at Seattle Children's Research Institute reprograms a patient's T cells so they can hunt down and destroy cancer cells wherever they are hiding in the body. Another key finding from Phase 1 is that of the patients who achieved initial remission, about 50% are still in remission one year after therapy. For the patients that relapsed, researchers have found that their reprogrammed T cells are no longer present or the cancer has evolved to circumvent the T cells. The first phase of PLAT-02 was integral in establishing the safety of the therapy and the optimal dose of T cells. Phase 2 will demonstrate how this therapy works for a larger group of patients.

Jeff Brown Joins as Senior Vice President, CIO of Seattle Children's Hospital

Seattle Children's announced that Jeff Brown has been appointed to the position of senior vice president and chief information officer of Seattle Children's effective Feb. 1. Brown has filled the CIO role at Seattle Children's on an interim basis since April 2015. In April 2015, Brown joined Seattle Children's from Lawrence General Hospital in Lawrence, Mass., where he served as CIO. In that role, Brown focused on mobilizing healthcare information electronically across an integrated healthcare system, accountable care organization (ACO) design, as well as population health and organization-wide digital healthcare strategies.

Seattle Children's Appoints Lisa Rediger Hayward as Senior Vice President and General Counsel, Effective January 4, 2016

Seattle Children's announced that Lisa Rediger Hayward has been appointed to the position of senior vice president and general counsel of Seattle Children's effective Jan. 4, 2016. Hayward replaces Jeff Sconyers, who retired earlier 2015. Hayward, 48, is currently a partner at Davis Wright Tremaine, LLP in Seattle, where she will remain until she transitions to Seattle Children's. In that position, Hayward has worked closely with health systems, hospitals and multi-specialty medical groups on a wide range of regulatory and transactional matters. Some of her key accomplishments included assisting in the development of accountable care organizations as well as clinically integrated networks and advising health systems in Washington's certificate of need process.

Similar Private Companies By Industry

Company Name Region
@ Home Medical, Inc. United States
@home approach, llc United States
@Home Care United States
1011 E. Pecan Grove Road, LLC United States
1125 Sir Francis Drake Boulevard Operating Company, Llc United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Bloomberg L.P. United States
NYC2012, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Seattle Childrens Hospital, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at